Print

Promosome LLC and Recopharma AB Announce Technology Partnership  
5/19/2010 8:32:03 AM

NEW YORK, May 19, 2010 (GLOBE NEWSWIRE) -- Promosome LLC, a biotechnology company uniquely dedicated to the development of technologies related to the regulation of protein synthesis through translation initiation, today announced the signing of a technology license and partnership agreement with Recopharma AB of Stockholm, Sweden. Recopharma is a recognized leader in the research and development of therapeutic recombinant mucin-type fusion proteins.
//-->